tiprankstipranks
Trending News
More News >
Sedana Medical AB (DE:7D2A)
FRANKFURT:7D2A

Sedana Medical AB (7D2A) Price & Analysis

Compare
0 Followers

7D2A Stock Chart & Stats


---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.12%99.58%
Insiders
0.12%
Mutual Funds
― Other Institutional Investors
99.58% Public Companies and
Individual Investors

7D2A FAQ

What was Sedana Medical AB’s price range in the past 12 months?
Sedana Medical AB lowest stock price was €0.58 and its highest was €2.39 in the past 12 months.
    What is Sedana Medical AB’s market cap?
    Sedana Medical AB’s market cap is €93.28M.
      When is Sedana Medical AB’s upcoming earnings report date?
      Sedana Medical AB’s upcoming earnings report date is May 06, 2025 which is today.
        How were Sedana Medical AB’s earnings last quarter?
        Sedana Medical AB released its earnings results on Feb 13, 2025. The company reported €0.008 earnings per share for the quarter, beating the consensus estimate of -€0.009 by €0.018.
          Is Sedana Medical AB overvalued?
          According to Wall Street analysts Sedana Medical AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sedana Medical AB pay dividends?
            Sedana Medical AB does not currently pay dividends.
            What is Sedana Medical AB’s EPS estimate?
            Sedana Medical AB’s EPS estimate is >-0.01.
              How many shares outstanding does Sedana Medical AB have?
              Sedana Medical AB has 99,336,960 shares outstanding.
                What happened to Sedana Medical AB’s price movement after its last earnings report?
                Sedana Medical AB reported an EPS of €0.008 in its last earnings report, beating expectations of -€0.009. Following the earnings report the stock price went up 8.176%.
                  Which hedge fund is a major shareholder of Sedana Medical AB?
                  Currently, no hedge funds are holding shares in DE:7D2A
                  ---

                  Company Description

                  Sedana Medical AB

                  Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-, which are disposable medical devices that enables the administration of volatile anesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and FlurAbsorb mount to hold the filter during scavenging of anesthetic gas. It also provides AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and various accessories comprising DRYLINE II Water Traps, WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Line. Sedana Medical AB (publ) was founded in 1999 and is headquartered in Danderyd, Sweden.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Bactiguard Holding AB
                  C-Rad AB Class B
                  Integrum AB Class B
                  Acarix AB
                  Mentice AB
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis